A tree-based explainable AI model for early detection of Covid-19 using physiological data.

With the outbreak of COVID-19 in 2020, countries worldwide faced significant concerns and challenges. Various studies have emerged utilizing Artificial Intelligence (AI) and Data Science techniques for disease detection. Although COVID-19 cases have declined, there are still cases and deaths around the world. Therefore, early detection of COVID-19 before the onset of symptoms has become crucial in reducing its extensive impact. Fortunately, wearable devices such as smartwatches have proven to be valuable sources of physiological data, including Heart Rate (HR) and sleep quality, enabling the detection of inflammatory diseases. In this study, we utilize an already-existing dataset that includes individual step counts and heart rate data to predict the probability of COVID-19 infection before the onset of symptoms. We train three main model architectures: the Gradient Boosting classifier (GB), CatBoost trees, and TabNet classifier to analyze the physiological data and compare their respective performances. We also add an interpretability layer to our best-performing model, which clarifies prediction results and allows a detailed assessment of effectiveness. Moreover, we created a private dataset by gathering physiological data from Fitbit devices to guarantee reliability and avoid bias.The identical set of models was then applied to this private dataset using the same pre-trained models, and the results were documented. Using the CatBoost tree-based method, our best-performing model outperformed previous studies with an accuracy rate of 85% on the publicly available dataset. Furthermore, this identical pre-trained CatBoost model produced an accuracy of 81% when applied to the private dataset. You will find the source code in the link: https://github.com/OpenUAE-LAB/Covid-19-detection-using-Wearable-data.git .

Wearable Devices and Explainable Unsupervised Learning for COVID-19 Detection and Monitoring.

Despite the declining COVID-19 cases, global healthcare systems still face significant challenges due to ongoing infections, especially among fully vaccinated individuals, including adolescents and young adults (AYA). To tackle this issue, cost-effective alternatives utilizing technologies like Artificial Intelligence (AI) and wearable devices have emerged for disease screening, diagnosis, and monitoring. However, many AI solutions in this context heavily rely on supervised learning techniques, which pose challenges such as human labeling reliability and time-consuming data annotation. In this study, we propose an innovative unsupervised framework that leverages smartwatch data to detect and monitor COVID-19 infections. We utilize longitudinal data, including heart rate (HR), heart rate variability (HRV), and physical activity measured via step count, collected through the continuous monitoring of volunteers. Our goal is to offer effective and affordable solutions for COVID-19 detection and monitoring. Our unsupervised framework employs interpretable clusters of normal and abnormal measures, facilitating disease progression detection. Additionally, we enhance result interpretation by leveraging the language model Davinci GPT-3 to gain deeper insights into the underlying data patterns and relationships. Our results demonstrate the effectiveness of unsupervised learning, achieving a Silhouette score of 0.55. Furthermore, validation using supervised learning techniques yields high accuracy (0.884 ± 0.005), precision (0.80 ± 0.112), and recall (0.817 ± 0.037). These promising findings indicate the potential of unsupervised techniques for identifying inflammatory markers, contributing to the development of efficient and reliable COVID-19 detection and monitoring methods. Our study shows the capabilities of AI and wearables, reflecting the pursuit of low-cost, accessible solutions for addressing health challenges related to inflammatory diseases, thereby opening new avenues for scalable and widely applicable health monitoring solutions.

Infant Cry Signal Diagnostic System Using Deep Learning and Fused Features.

Early diagnosis of medical conditions in infants is crucial for ensuring timely and effective treatment. However, infants are unable to verbalize their symptoms, making it difficult for healthcare professionals to accurately diagnose their conditions. Crying is often the only way for infants to communicate their needs and discomfort. In this paper, we propose a medical diagnostic system for interpreting infants' cry audio signals (CAS) using a combination of different audio domain features and deep learning (DL) algorithms. The proposed system utilizes a dataset of labeled audio signals from infants with specific pathologies. The dataset includes two infant pathologies with high mortality rates, neonatal respiratory distress syndrome (RDS), sepsis, and crying. The system employed the harmonic ratio (HR) as a prosodic feature, the Gammatone frequency cepstral coefficients (GFCCs) as a cepstral feature, and image-based features through the spectrogram which are extracted using a convolution neural network (CNN) pretrained model and fused with the other features to benefit multiple domains in improving the classification rate and the accuracy of the model. The different combination of the fused features is then fed into multiple machine learning algorithms including random forest (RF), support vector machine (SVM), and deep neural network (DNN) models. The evaluation of the system using the accuracy, precision, recall, F1-score, confusion matrix, and receiver operating characteristic (ROC) curve, showed promising results for the early diagnosis of medical conditions in infants based on the crying signals only, where the system achieved the highest accuracy of 97.50% using the combination of the spectrogram, HR, and GFCC through the deep learning process. The finding demonstrated the importance of fusing different audio features, especially the spectrogram, through the learning process rather than a simple concatenation and the use of deep learning algorithms in extracting sparsely represented features that can be used later on in the classification problem, which improves the separation between different infants' pathologies. The results outperformed the published benchmark paper by improving the classification problem to be multiclassification (RDS, sepsis, and healthy), investigating a new type of feature, which is the spectrogram, using a new feature fusion technique, which is fusion, through the learning process using the deep learning model.

Newborn Cry-Based Diagnostic System to Distinguish between Sepsis and Respiratory Distress Syndrome Using Combined Acoustic Features.

Crying is the only means of communication for a newborn baby with its surrounding environment, but it also provides significant information about the newborn's health, emotions, and needs. The cries of newborn babies have long been known as a biomarker for the diagnosis of pathologies. However, to the best of our knowledge, exploring the discrimination of two pathology groups by means of cry signals is unprecedented. Therefore, this study aimed to identify septic newborns with Neonatal Respiratory Distress Syndrome (RDS) by employing the Machine Learning (ML) methods of Multilayer Perceptron (MLP) and Support Vector Machine (SVM). Furthermore, the cry signal was analyzed from the following two different perspectives: 1) the musical perspective by studying the spectral feature set of Harmonic Ratio (HR), and 2) the speech processing perspective using the short-term feature set of Gammatone Frequency Cepstral Coefficients (GFCCs). In order to assess the role of employing features from both short-term and spectral modalities in distinguishing the two pathology groups, they were fused in one feature set named the combined features. The hyperparameters (HPs) of the implemented ML approaches were fine-tuned to fit each experiment. Finally, by normalizing and fusing the features originating from the two modalities, the overall performance of the proposed design was improved across all evaluation measures, achieving accuracies of 92.49% and 95.3% by the MLP and SVM classifiers, respectively. The MLP classifier was outperformed in terms of all evaluation measures presented in this study, except for the Area Under Curve of Receiver Operator Characteristics (AUC-ROC), which signifies the ability of the proposed design in class separation. The achieved results highlighted the role of combining features from different levels and modalities for a more powerful analysis of the cry signals, as well as including a neural network (NN)-based classifier. Consequently, attaining a 95.3% accuracy for the separation of two entangled pathology groups of RDS and sepsis elucidated the promising potential for further studies with larger datasets and more pathology groups.

Wearable Devices, Smartphones, and Interpretable Artificial Intelligence in Combating COVID-19.

Physiological measures, such as heart rate variability (HRV) and beats per minute (BPM), can be powerful health indicators of respiratory infections. HRV and BPM can be acquired through widely available wrist-worn biometric wearables and smartphones. Successive abnormal changes in these indicators could potentially be an early sign of respiratory infections such as COVID-19. Thus, wearables and smartphones should play a significant role in combating COVID-19 through the early detection supported by other contextual data and artificial intelligence (AI) techniques. In this paper, we investigate the role of the heart measurements (i.e., HRV and BPM) collected from wearables and smartphones in demonstrating early onsets of the inflammatory response to the COVID-19. The AI framework consists of two blocks: an interpretable prediction model to classify the HRV measurements status (as normal or affected by inflammation) and a recurrent neural network (RNN) to analyze users' daily status (i.e., textual logs in a mobile application). Both classification decisions are integrated to generate the final decision as either "potentially COVID-19 infected" or "no evident signs of infection". We used a publicly available dataset, which comprises 186 patients with more than 3200 HRV readings and numerous user textual logs. The first evaluation of the approach showed an accuracy of 83.34 ± 1.68% with 0.91, 0.88, 0.89 precision, recall, and F1-Score, respectively, in predicting the infection two days before the onset of the symptoms supported by a model interpretation using the local interpretable model-agnostic explanations (LIME).